Inhibition of PREX1 Reverses Enzalutamide Resistance in Castration-Resistant Prostate CancerChung Un Lee(Chung-Ang University Hospital), Seong Il Seo(Samsung Medical Center)The World Journal of Men s HealthJanuary 1, 202510.5534/wjmh.250135Cited by 1SaveCiteExport RISWatch citationsRelated PapersISL1 promotes enzalutamide resistance in castration-resistant prostate cancer (CRPC) through epithelial to mesenchymal transition (EMT)|Scientific Reports|2021|22ISL1 Romotes Enzalutamide Resistance in Castration-resistant Prostate Cancer (CRPC) through Epithelial to Mesenchymal Transition (EMT)|Research Square|2021|0